Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.6450
0.0000
(0.00%)
As of March 3 at 4:22:34 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-75,696
-66,930
-65,045
-55,771
-77,021
Investing Cash Flow
57,946
-3,087
226,417
-74,540
27,779
Financing Cash Flow
32,179
29,589
-155,292
121,187
32,705
End Cash Position
24,764
7,848
48,596
43,343
52,250
Income Tax Paid Supplemental Data
25
21
--
36
48
Interest Paid Supplemental Data
19
1,171
8,535
7,155
7,202
Capital Expenditure
-8,601
-1,536
-4,924
-7,247
-7,527
Issuance of Capital Stock
31,833
72,808
--
121,045
35,000
Issuance of Debt
--
--
--
--
10,005
Repayment of Debt
--
-43,219
-155,293
-466
-12,417
Free Cash Flow
-84,297
-68,466
-69,969
-63,018
-84,548
12/31/2020 - 12/2/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
26CA.MU ImmunityBio Inc
3.1250
+7.39%
GBM.F Inovio Pharmaceuticals, Inc.
1.7500
-6.91%
OKUR OnKure Therapeutics, Inc.
4.8300
-4.73%
SLN Silence Therapeutics plc
4.3200
-4.00%
CNTA Centessa Pharmaceuticals plc
15.04
-3.28%
BCYC Bicycle Therapeutics plc
10.47
-4.56%
REPL Replimune Group, Inc.
12.12
-4.42%
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%
IBRX ImmunityBio, Inc.
2.8500
-13.37%
VKTX Viking Therapeutics, Inc.
25.70
-10.98%